mani
pathogen
respiratori
syncyti
viru
influenza
viru
develop
protect
vaccin
elus
despit
decad
effort
mani
case
failur
appear
absolut
inabl
immun
system
produc
protect
antibodi
sinc
character
infect
individu
beeler
van
wyke
coelingh
burton
et
al
okuno
et
al
johnson
et
al
karron
et
al
scanlan
et
al
kashyap
et
al
throsbi
et
al
ekiert
et
al
scheid
et
al
sui
et
al
walker
et
al
wu
et
al
corti
et
al
dreyfu
et
al
huang
et
al
magro
et
al
mouquet
et
al
liao
et
al
ngwuta
et
al
entir
clear
tradit
vaccin
develop
approach
fail
induc
similar
protect
antibodi
mount
evid
suggest
protect
vaccin
pathogen
like
need
stimul
specif
lineag
antibodi
target
defin
epitop
pantaleo
koup
rappuoli
et
al
lang
et
al
robbiani
et
al
goodwin
et
al
kwong
mascola
contrast
tradit
vaccin
gener
stimul
polyclon
antibodi
respons
whole
pathogen
larg
subunit
pathogen
rather
focu
immun
respons
toward
known
protect
epitop
observ
subset
individu
develop
broadli
neutral
antibodi
bnab
target
envelop
protein
env
capabl
neutral
divers
viral
isol
cours
infect
demonstr
human
immun
system
capabl
gener
bnab
respons
provid
receiv
appropri
antigen
stimul
inde
numer
bnab
isol
infect
individu
defin
site
vulner
mechan
neutral
west
et
al
burton
hangartn
kwong
mascola
importantli
bnab
shown
protect
experiment
infect
anim
model
suggest
import
compon
effect
vaccin
mascola
et
al
shibata
et
al
parren
et
al
hessel
et
al
moldt
et
al
pietzsch
et
al
gruell
et
al
balaz
et
al
shingai
et
al
gautam
et
al
liu
et
al
unfortun
bnab
elicit
vaccin
human
despit
use
divers
recombin
envderiv
immunogen
immun
scheme
burton
et
al
cohen
dolin
schiffner
et
al
recent
advanc
amplif
antibodi
gene
individu
b
cell
reveal
bnab
often
requir
extens
somat
mutat
achiev
broad
potent
neutral
activ
scheid
et
al
dimitrov
klein
et
al
kwong
et
al
mascola
hayn
west
et
al
although
mutat
bnab
capabl
broad
env
recognit
viru
neutral
infer
germlin
bnab
variant
display
reactiv
env
variant
test
led
us
other
propos
one
reason
lack
bnab
elicit
immun
lack
stimul
b
cell
express
bnab
progenitor
b
cell
receptor
bcr
envbas
immunogen
xiao
et
al
hoot
et
al
jardin
et
al
mcguir
et
al
andrabi
et
al
zhou
et
al
gorman
et
al
envbas
immunogen
capabl
bind
certain
germlin
bnab
recent
develop
effect
activ
b
cell
knockin
mice
express
desir
bcr
vivo
dosenov
et
al
escolano
et
al
jardin
et
al
mcguir
et
al
steichen
et
al
abbott
et
al
mani
bnab
howev
antigen
capabl
bound
correspond
germlin
form
yet
identifi
design
demonstr
use
antiidiotyp
altern
approach
structurebas
immunogen
design
target
infer
germlin
version
bnab
focus
upon
despit
one
first
bnab
isol
envbas
immunogen
identifi
develop
recogn
ancestr
germlin
form
xiao
et
al
hoot
et
al
matur
form
isol
phage
display
barba
et
al
use
heavi
chain
deriv
light
chain
deriv
xiao
et
al
hoot
et
al
use
antiidiotyp
specif
infer
germlin
version
bait
singl
b
cell
sort
identifi
subset
human
germlin
bcr
use
heavi
chain
similar
crystal
structur
indic
one
idiotyp
made
extens
contact
region
encod
gene
segment
enrich
sort
b
cell
moreov
could
identifi
region
amino
acid
sequenc
ident
within
dataset
includ
hundr
bcr
light
hypothes
b
cell
express
bcr
contain
high
similar
may
delet
repertoir
result
autoreact
selfantigen
line
notion
demonstr
antibodi
stain
cell
featur
autoreact
antibodi
hayn
et
al
verkoczi
et
al
ota
et
al
evalu
consequ
autoreact
vivo
gener
mice
heavi
chain
knock
endogen
murin
heavi
chain
locu
heavi
chain
knockin
mice
exhibit
b
cell
delet
develop
surviv
b
cell
exhibit
bcr
downregul
anergi
despit
presenc
anergi
immun
multimer
version
idiotyp
stimul
prolifer
differenti
transgen
b
cell
express
heavi
chain
summari
result
establish
proof
concept
antiidiotyp
use
immunogen
identifi
stimul
ancestr
germlin
version
protect
antibodi
gener
antiidiotyp
antibodi
hoot
et
al
immun
boost
mice
intraperiton
adjuv
final
immun
splenocyt
isol
fuse
myeloma
cell
result
gener
hundr
hybridoma
produc
antibodi
abl
bind
nearli
clone
exclud
bound
panel
control
germlin
antibodi
well
suggest
specif
heavi
light
chain
constant
region
human
ig
data
shown
importantli
four
clone
exhibit
bind
similar
appar
affin
dissoci
constant
kd
bind
panel
control
antibodi
deriv
germlin
bcr
sequenc
antibodi
fig
tabl
idiotyp
also
fail
bind
fulli
matur
version
indic
prefer
unmut
sequenc
fig
c
one
clone
bound
chimera
express
heavi
chain
noncogn
control
light
chain
three
clone
bind
chimera
fig
c
suggest
differ
mode
recognit
next
assess
whether
bind
clone
specif
heavi
chain
region
oppos
depend
variabl
gene
segment
use
consist
clone
specif
recogn
featur
uniqu
four
clone
fail
bind
natur
pair
control
antibodi
use
dekoski
et
al
whether
pair
light
chain
light
chain
deriv
fig
c
togeth
data
suggest
four
clone
preferenti
recogn
idiotyp
among
four
idiotyp
identifi
screen
focus
upon
solv
crystal
structur
complex
resolut
respect
crystal
structur
reveal
display
distinct
mode
interact
fig
interact
heavi
light
chain
fig
consist
biolay
interferometri
bli
data
fig
c
interact
occur
within
heavi
chain
fig
b
c
contribut
buri
surfac
area
bsa
six
eight
hydrogen
bond
one
hydrogen
bond
occur
region
remain
six
hydrogen
bond
bsa
occur
framework
region
encod
fig
e
contrast
approach
angl
rel
bound
exclus
heavi
chain
fig
f
region
contribut
nearli
half
bsa
two
six
hydrogen
bond
remain
bsa
hydrogen
bond
larg
focus
upon
encod
fig
extens
interact
heavi
chain
like
explain
bind
antibodi
use
fig
c
next
assess
whether
idiotyp
could
use
identifi
b
cell
express
bcr
within
polyclon
human
b
cell
repertoir
hivuninfect
individu
use
singl
b
cell
sort
follow
rtpcr
amplif
sequenc
heavi
light
chain
gene
initi
set
experi
biotinyl
tetramer
use
streptavidin
conjug
allophycocyanin
apc
incub
togeth
million
human
peripher
blood
mononuclear
cell
pbmc
enrich
use
antiapc
microbead
use
approach
b
cell
apcenrich
fraction
bound
isotyp
control
tetram
fig
highlight
effici
enrich
approach
b
cell
could
detect
apcdeplet
fraction
fig
use
approach
singl
b
cell
bind
tetram
sort
individu
well
plate
heavi
light
chain
express
cell
sequenc
use
nest
rtpcr
tiller
et
al
total
facspurifi
singl
b
cell
individu
yield
heavi
chain
light
chain
sequenc
heavi
light
chain
pair
tabl
confirm
specif
flow
cytometri
approach
antibodi
produc
pair
heavi
light
chain
cell
antibodi
bound
assess
bli
fig
b
interestingli
eight
antibodi
bound
use
heavi
chain
variabl
region
two
antibodi
fail
bind
antiidiotyp
use
vh
allel
tabl
two
clone
antibodi
heavi
chain
pair
light
chain
suggest
lack
bind
due
absenc
segment
fig
c
result
highlight
high
specif
flow
cytometri
approach
suggest
bound
higher
number
cell
compar
antiidiotyp
gain
indepth
understand
bcr
recogn
individu
antiidiotyp
antibodi
next
conduct
sort
label
differ
fluorophor
focus
analysi
antiidiotyp
highresolut
crystal
structur
complex
allow
us
make
predict
bcr
may
preferenti
recogn
crystal
structur
predict
would
highli
select
b
cell
express
bcr
use
region
similar
contrast
predict
would
select
b
cell
express
bcr
use
divers
pair
light
chain
similar
due
random
natur
v
j
recombin
give
rise
region
expect
find
b
cell
express
ident
test
predict
biotinyl
tetramer
use
streptavidin
conjug
apc
rphycoerythrin
pe
stain
pbmc
antiidiotyp
tetram
reveal
live
b
cell
popul
hivuninfect
individu
bound
respect
isotyp
control
tetram
fig
easili
identifi
rare
b
cell
bind
andor
tetramerbind
cell
enrich
use
apcspecif
pespecif
magnet
microbead
sampl
million
pbmc
flow
cytometri
fig
use
approach
singl
b
cell
bind
andor
tetram
sort
individu
well
plate
heavi
kappa
light
chain
express
cell
sequenc
use
nest
rtpcr
tiller
et
al
total
facspurifi
singl
b
cell
singl
b
cell
three
individu
b
cell
obtain
heavi
chain
kappa
light
chain
sequenc
heavi
light
chain
pair
tabl
b
cell
yield
heavi
chain
kappa
light
chain
sequenc
heavi
light
chain
pair
tabl
unabl
recov
heavi
light
chain
sequenc
small
number
sort
cell
bind
tetram
bcr
sequenc
b
cell
bind
next
compar
averag
b
cell
three
individu
use
vh
gene
fig
b
contrast
individu
sort
b
cell
express
neither
antiidiotyp
use
select
cell
sort
fig
b
consist
previou
studi
dekoski
et
al
term
entir
b
cell
repertoir
averag
b
cell
bound
use
fig
c
contrast
b
cell
use
amount
b
cell
repertoir
fig
b
c
consist
crystal
structur
reveal
interact
heavi
light
chain
fig
b
c
four
five
bcr
light
chain
sequenc
recov
use
light
chain
close
relat
fig
surprisingli
bcr
exhibit
slight
prefer
fig
predict
heavi
mode
bind
indic
crystal
structur
fig
next
examin
uniqu
heavi
chain
region
use
bcr
search
similar
sinc
abl
detect
bcr
dataset
bcr
includ
analysi
crystal
structur
bound
reveal
bsa
contribut
fig
j
nearli
bsa
ie
total
bsa
focus
portion
encod
fig
e
howev
bcr
use
differ
control
bcr
fig
f
region
bcr
two
similar
display
amino
acid
ident
fig
g
moder
similar
bcr
sequenc
led
us
consid
whether
biolog
mechan
select
close
match
specif
hypothes
heavi
chain
autoreact
result
delet
similar
sequenc
b
cell
repertoir
autoreact
report
conflict
report
autoreact
report
matur
form
one
studi
report
matur
exhibit
autoreact
use
vitro
assay
hayn
et
al
ota
et
al
howev
b
cell
develop
transgen
mice
express
antibodi
normal
ota
et
al
preliminari
assess
potenti
autoreact
measur
bind
human
cell
use
immunofluoresc
approach
reveal
bound
moder
cell
compar
fig
b
hivspecif
antibodi
previous
shown
exhibit
bind
assay
hayn
et
al
verkoczi
et
al
stain
similar
matur
form
brighter
fig
b
antibodi
previous
shown
nonreact
assay
hayn
et
al
verkoczi
et
al
togeth
data
suggest
autoreact
assess
whether
autoreact
detect
assay
result
function
consequ
vivo
gener
transgen
mous
b
cell
express
heavi
chain
previou
work
demonstr
b
cell
bcr
knockin
mice
express
matur
delet
repertoir
consequ
autoreact
doylecoop
et
al
ota
et
al
found
heavi
chain
transgen
mice
display
three
fourfold
reduct
number
matur
b
cell
spleen
compar
wt
mice
mice
express
control
infer
germlin
heavi
chain
gener
use
knockin
strategi
jardin
et
al
fig
b
delet
could
trace
back
immatur
stage
bone
marrow
heavi
chain
transgen
mice
contain
approxim
twofold
fewer
igm
matur
b
cell
compar
wt
control
transgen
anim
fig
c
togeth
data
indic
signific
portion
murin
b
cell
express
heavi
chain
delet
bone
marrow
previou
studi
shown
autoreact
b
cell
escap
delet
often
render
function
unrespons
antigen
stimul
state
refer
anergi
goodnow
et
al
cyster
et
al
fulcher
basten
klinman
nemaze
given
next
consid
whether
b
cell
remain
heavi
chain
transgen
mice
anerg
previous
sever
phenotyp
anerg
b
cell
describ
mice
includ
igmlow
transit
phenotyp
well
matur
b
cell
express
low
level
igm
allman
et
al
merrel
et
al
taylor
et
al
agraw
et
al
sabouri
et
al
agreement
hypothesi
circul
heavi
chain
transgen
b
cell
anerg
number
cell
increas
anim
compar
control
transgen
anim
fig
c
e
addit
igm
express
lower
matur
b
cell
heavi
chain
transgen
mice
compar
control
heavi
chain
transgen
anim
fig
igd
express
also
reduc
matur
b
cell
heavi
chain
transgen
mice
compar
control
transgen
anim
fig
b
suggest
global
downregul
surfac
bcr
cell
downregul
surfac
bcr
express
heavi
chain
transgen
matur
b
cell
confirm
assess
fig
c
compon
bcr
signal
complex
requir
surfac
bcr
express
increas
frequenc
heavi
chain
transgen
b
cell
exhibit
anerg
phenotyp
combin
decreas
bcr
express
suggest
cell
would
respond
poorli
bcr
stimul
test
label
purifi
matur
b
cell
wt
heavi
chain
transgen
mice
celltrac
violet
ctv
incub
vari
concentr
antiig
h
vitro
analysi
concentr
antiig
fewer
heavi
chain
transgen
b
cell
dilut
ctv
compar
b
cell
wt
mice
fig
b
data
suggest
heavi
chain
transgen
b
cell
escap
delet
function
anerg
combin
stain
data
murin
data
suggest
heavi
chain
autoreact
support
hypothesi
delet
anergi
bcr
occur
human
presenc
anergi
within
heavi
chain
transgen
b
cell
suggest
immunogen
target
popul
would
need
overcom
function
defect
perform
immun
experi
modifi
ensur
optim
murin
respons
sinc
gener
mous
would
like
gener
poor
respons
inject
unmodifi
sinc
toler
mechan
would
expect
elimin
sourc
cell
help
target
increas
possibl
cell
help
heavi
light
chain
constant
region
use
antiidiotyp
human
tiller
et
al
sinc
multimer
overcom
anerg
respons
cook
et
al
gautam
et
al
mcguir
et
al
human
antigenbind
fragment
fab
fuse
modifi
multimer
domain
chicken
protein
selfassembl
multim
contain
seven
human
fab
domain
ogun
et
al
hofmey
et
al
garner
cell
help
epitop
ree
et
al
ad
cterminu
separ
cathepsin
consensu
sequenc
order
promot
endosom
process
mhc
present
schneider
et
al
immun
experi
b
cell
heavi
chain
transgen
mice
label
ctv
transfer
wt
recipi
mice
transfer
mice
immun
irrelev
human
isotyp
fusion
follow
inject
donor
b
cell
account
averag
total
b
cell
control
recipi
anim
detect
enrich
cell
analysi
fig
b
expect
rest
cell
encount
antigen
therefor
prolifer
cell
larg
retain
high
level
ctv
fig
c
contrast
follow
inject
donor
b
cell
increas
twofold
averag
total
b
cell
fig
approxim
half
donor
b
cell
low
level
ctv
indic
prolifer
account
increas
frequenc
donor
cell
fig
addit
expans
transgen
b
cell
mice
bound
downregul
fig
e
f
phenotyp
germin
center
b
cell
allen
et
al
kurosaki
et
al
victora
et
al
vinuesa
et
al
kitano
et
al
experi
germin
center
b
cell
deriv
transgen
donor
recipi
anim
could
detect
use
tetram
fig
analysi
reveal
transgen
b
cell
account
germin
center
b
cell
fig
frequenc
repres
increas
transgen
cell
found
cell
outsid
germin
center
inject
anim
fig
togeth
result
indic
idiotyp
antibodi
use
immunogen
overcom
anergi
induc
b
cell
activ
entri
germin
center
result
demonstr
antiidiotyp
antibodi
identifi
activ
bnab
precursor
b
cell
vivo
repres
potenti
altern
complement
structurebas
immunogen
design
antiidiotyp
present
sever
advantag
first
antigen
deriv
pathogen
gener
difficult
produc
often
highli
unstabl
difficult
maintain
desir
conform
especi
inject
manufactur
standpoint
antiidiotyp
easili
produc
identifi
would
expect
highli
stabl
vivo
evidenc
licensur
sever
therapeut
antibodi
anoth
advantag
approach
one
could
simultan
use
numer
antiidiotyp
stimul
multipl
potenti
protect
lineag
howev
must
recogn
unlik
inject
singl
antiidiotyp
contain
immunogen
would
induc
product
protect
antibodi
situat
high
level
somat
mutat
requir
scheid
et
al
dimitrov
pancera
et
al
zhou
et
al
hayn
et
al
mouquet
et
al
jardin
et
al
klein
et
al
b
mcguir
et
al
escolano
et
al
situat
success
inject
immunogen
contain
antiidiotyp
increasingli
matur
antibodi
may
guid
antibodi
matur
toward
highli
protect
antibodi
altern
antiidiotyp
may
better
suit
activ
protect
antibodi
requir
less
somat
mutat
neutral
middl
east
respiratori
syndrom
agraw
et
al
respiratori
syncyti
viru
goodwin
et
al
first
step
matur
pathway
includ
pathogenderiv
antigen
subsequ
boost
identifi
four
clone
produc
idiotyp
use
multiplex
screen
approach
evalu
thousand
hybridoma
futur
studi
screen
burden
reduc
enrich
sort
b
cell
express
bcr
desir
bind
properti
andor
hybridoma
fusion
taylor
et
al
spanier
et
al
knowledg
studi
repres
first
time
antiidiotyp
use
identifi
analyz
naiv
b
cell
express
bcr
similar
infer
germlin
sequenc
broadli
neutral
antibodi
import
result
within
analys
find
differ
antiidiotyp
antibodi
differ
mode
interact
bcr
similar
one
interest
bind
profil
analysi
fig
c
crystal
structur
data
fig
suggest
would
select
bcr
heavi
chain
would
select
bcr
heavi
light
chain
perhap
subset
popul
sort
sequenc
bcr
human
b
cell
therefor
import
reveal
select
complet
differ
popul
cell
select
far
stringent
bcr
compar
given
find
explor
way
better
predict
antiidiotyp
better
identifi
bcr
interest
nevertheless
result
indic
probe
preimmun
repertoir
antiidiotyp
potenti
immunogen
inform
step
vaccin
design
cours
sequenc
experi
screen
equival
million
b
cell
identifi
sequenc
recogn
antiidiotyp
show
amino
acid
ident
conceiv
antiidiotyp
abl
recogn
rare
sequenc
higher
ident
unabl
identifi
due
limit
effici
cell
sort
bcr
sequenc
abil
screen
larger
number
cell
current
exce
capac
obtain
use
enrich
cell
sort
combin
dropletbas
bcr
sequenc
approach
nevertheless
absenc
sequenc
high
similar
led
us
hypothes
sequenc
may
purg
repertoir
due
autoreact
support
hypothesi
came
stain
cell
experi
b
cell
delet
anergi
observ
transgen
mice
express
heavi
chain
toler
effect
may
explain
bnab
commonli
identifi
hivinfect
individu
sever
studi
contrast
bnab
specif
present
identifi
larg
fraction
subject
develop
bnab
respons
target
supersit
pancera
et
al
landai
et
al
rusert
et
al
dits
et
al
exist
delet
anergi
mice
suggest
immun
strategi
abl
overcom
toler
may
requir
stimul
product
bnab
human
need
overcom
toler
uniqu
knockin
mice
sinc
delet
anergi
also
detect
mice
express
infer
germlin
form
bnab
mcguir
et
al
zhang
et
al
autoreact
uniqu
featur
hivspecif
lineag
detect
assess
influenza
bnab
andrew
et
al
bajic
et
al
notabl
remain
possibl
toler
exhibit
transgen
mice
express
heavi
chain
artifact
inabl
accur
infer
true
unmut
heavi
chain
matur
antibodi
exampl
sequenc
contain
two
n
region
infer
instead
carri
matur
sequenc
possibl
true
germlin
heavi
chain
differ
sequenc
locat
would
result
delet
anergi
importantli
activ
germin
center
entri
b
cell
first
step
matur
process
lineag
would
need
guid
toward
broad
env
bind
neutral
like
requir
mani
round
mutat
select
futur
work
explor
whether
prime
boost
experi
env
use
guid
matur
bnab
respons
overal
studi
demonstr
util
use
antiidiotyp
identifi
stimul
b
cell
express
desir
bcr
futur
work
aim
includ
antiidiotyp
vaccin
design
process
tool
identifi
cell
interest
immunogen
blood
obtain
venipunctur
healthi
hivseroneg
adult
volunt
enrol
gener
qualiti
control
studi
seattl
wa
approv
fred
hutchinson
cancer
research
center
institut
review
board
inform
consent
obtain
studi
particip
enrol
parent
protocol
pbmc
isol
whole
blood
use
accuspin
system
sigmaaldrich
resuspend
dimethylsulfoxid
heatinactiv
fetal
bovin
serum
cryopreserv
liquid
nitrogen
use
experi
perform
accord
relev
institut
nation
guidelin
approv
fred
hutchinson
cancer
research
center
institut
anim
care
use
committe
male
femal
wt
pepcbboyj
mice
purchas
jackson
laboratori
bred
hous
gener
heavi
chain
transgen
mice
control
heavi
chain
transgen
mice
perform
scripp
research
institut
mous
genet
core
facil
similarli
describ
previous
matur
heavi
chain
ota
et
al
briefli
cluster
replac
embryon
stem
cell
line
heavi
chain
vdj
exon
infer
germlin
heavi
chain
vdj
exon
mice
deriv
modifi
embryon
cell
carri
transgen
heavi
chain
interbr
homozyg
transgen
heavi
chain
male
femal
mice
use
experi
control
transgen
anim
express
heavi
chain
gener
ident
manner
jardin
et
al
sequenc
previous
report
hoot
et
al
sequenc
list
tabl
antiidiotyp
antibodi
gener
fred
hutchinson
cancer
research
center
antibodi
technolog
core
briefli
femal
balbc
mice
jackson
laboratori
immun
boost
intraperiton
adjuv
five
time
period
follow
final
boost
splenocyt
electrofus
myeloma
cell
thousand
hybridoma
coloni
screen
bind
panel
control
germlin
antibodi
hybridoma
produc
antibodi
specif
subclon
singl
cell
expand
antiidiotyp
purif
supernat
expand
hybridoma
harvest
purifi
protein
g
resin
pierc
follow
manufactur
recommend
produc
recombin
antiidiotyp
rna
extract
cell
use
rneasi
kit
qiagen
heavi
light
chain
sequenc
murin
hybridoma
obtain
use
mous
igprim
set
emd
millipor
use
protocol
develop
seigel
et
al
siegel
sequenc
codon
optim
clone
igg
express
vector
human
constant
region
snijder
et
al
use
infus
clone
clontech
purifi
antiidiotyp
antibodi
biotinyl
use
ezlink
sulfonhslcbiotinyl
kit
thermo
fisher
scientif
use
molar
ratio
biotin
antiidiotyp
unconjug
biotin
remov
centrifug
use
amicon
ultra
size
exclus
column
emd
millipor
determin
averag
number
biotin
molecul
bound
antiidiotyp
molecul
streptavidinp
prozym
titrat
fix
amount
biotinyl
antiidiotyp
increas
concentr
incub
room
temperatur
min
sampl
run
sdspage
gel
biorad
laboratori
transfer
nitrocellulos
incub
fluor
thermo
fisher
scientif
determin
point
excess
biotin
avail
fluor
reagent
bind
biotinyl
antiidiotyp
mix
streptavidinp
streptavidinapc
ratio
determin
fulli
satur
streptavidin
incub
min
room
temperatur
unconjug
antiidiotyp
remov
sever
round
dilut
concentr
use
nanosep
centrifug
devic
pall
corpor
control
tetram
creat
mix
isotyp
control
antibodi
streptavidinp
preconjug
dylight
streptavidinapc
preconjug
dylight
thermo
fisher
scientif
follow
manufactur
instruct
averag
contain
dylight
molecul
per
peapc
concentr
antiidiotyp
tetram
calcul
measur
absorb
pe
nm
extinct
coeffici
apc
nm
extinct
coeffici
lotspecif
ratio
streptavidinp
streptavidinapc
human
pbmc
analysi
frozen
cell
thaw
rpmi
fetal
bovin
serum
thermo
fisher
scientif
uml
penicillin
thermo
fisher
scientif
streptomycin
thermo
fisher
scientif
mm
sigmaaldrich
cell
centrifug
resuspend
ml
icecold
fac
buffer
compos
dulbecco
pb
dpb
newborn
calf
serum
thermo
fisher
scientif
contain
rat
mous
serum
control
antiidiotyp
tetram
ad
final
concentr
nm
incub
ice
min
allow
bind
b
cell
unwant
specif
tetram
ad
final
concentr
nm
incub
ice
min
follow
wash
icecold
fac
buffer
antip
andor
antiapcconjug
microbead
miltenyi
biotec
ad
incub
ice
min
ml
fac
buffer
ad
cell
mixtur
pass
magnet
ls
column
miltenyi
biotec
column
wash
ml
icecold
fac
buffer
remov
magnet
field
ml
icecold
fac
buffer
push
unmagnet
column
twice
use
plunger
elut
bound
cell
fraction
purifi
naiv
matur
b
cell
prepar
spleen
heavi
chain
transgen
mice
use
b
cell
neg
select
kit
miltenyi
biotec
supplement
biotinyl
ebiosci
remov
transit
b
cell
purifi
b
cell
wash
dpb
adjust
concentr
cellsml
warm
dpb
incub
ctv
thermo
fisher
scientif
min
wash
media
contain
fetal
bovin
serum
thermo
fisher
scientif
cell
resuspend
warm
dpb
cell
per
mous
inject
retroorbit
recipi
follow
transfer
recipi
mice
inject
intraperiton
ml
follow
solut
ml
dilut
sigma
adjuv
system
sigmaaldrich
human
version
contain
fab
fuse
epitop
eawgalanwavdsa
heptamer
nanoparticl
describ
previous
hofmey
et
al
ml
dpb
human
isotyp
control
dilut
sigma
adjuv
system
use
control
follow
inject
spleen
inguin
brachial
cervic
mesenter
lymph
node
harvest
dpb
minc
digest
describ
previous
taylor
et
al
dispas
mgml
thermo
fisher
scientif
collagenas
mgml
roch
dnase
mgml
roch
min
enzym
inactiv
mm
edta
singlecel
suspens
obtain
sampl
centrifug
cell
pellet
resuspend
ml
dpb
contain
newborn
calf
serum
bioxcel
biotin
ebiosci
enrich
use
antibiotin
microbead
miltenyi
biotec
describ
tetram
enrich
centrifug
supernat
discard
cell
pellet
resuspend
fac
buffer
entir
enrich
fraction
flowthrough
unenrich
fraction
incub
antibodi
surfac
marker
total
volum
min
ice
wash
fac
buffer
human
pbmc
label
antiigm
fitc
bd
bioscienc
antiigd
bd
bioscienc
efluor
ebiosci
bd
bioscienc
bd
bioscienc
bd
bioscienc
biolegend
bd
bioscienc
adopt
transfer
experi
mous
spleen
lymph
node
cell
label
fitc
bd
bioscienc
biolegend
alexa
fluor
ebiosci
biolegend
bd
bioscienc
biolegend
bd
bioscienc
bd
bioscienc
bd
bioscienc
bd
bioscienc
also
includ
detect
donor
cell
enrich
use
biotin
b
cell
subset
analysi
cell
label
fitc
bd
bioscienc
antiigd
bd
bioscienc
ebiosci
bd
bioscienc
bd
bioscienc
biolegend
bd
bioscienc
antiigmb
bd
bioscienc
bd
bioscienc
bd
bioscienc
bd
bioscienc
vitro
prolifer
experi
cell
label
bd
bioscienc
biolegend
bd
bioscienc
bd
bioscienc
experi
fixabl
viabil
dye
efluor
efluor
ebiosci
fixabl
viabil
stain
bd
bioscienc
includ
surfac
antibodi
cocktail
distinguish
live
dead
cell
flow
cytometri
perform
fivelas
nm
nm
nm
nm
nm
lsr
ii
lsrfortessa
facsaria
ii
facsymphoni
devic
bd
bioscienc
analyz
flowjo
softwar
tree
star
fluoresc
accucheck
count
bead
thermo
fisher
scientif
ad
sampl
flow
cytometri
use
calcul
total
number
cell
subtyp
columnbound
flowthrough
suspens
previous
describ
taylor
et
al
naiv
matur
b
cell
purifi
label
ctv
describ
adopt
transfer
experi
cell
adjust
concentr
cellsml
rpmi
thermo
fisher
scientif
contain
fetal
bovin
serum
thermo
fisher
scientif
uml
penicillin
thermo
fisher
scientif
mgml
streptomycin
mm
lglutamin
thermo
fisher
scientif
mgml
gentamicin
thermo
fisher
scientif
mm
sigmaaldrich
cell
sampl
ad
per
well
flat
bottom
plate
cell
cultur
presenc
absenc
f
goat
antimous
ig
jackson
immunoresearch
final
volum
ml
incub
h
analysi
flow
cytometri
singl
human
b
cell
isol
use
facsaria
ii
cell
sorter
diva
configur
bd
bioscienc
follow
tetram
enrich
cell
surfac
marker
stain
use
human
pbmc
describ
singl
b
cell
defin
subpopul
sort
accord
surfac
marker
express
pattern
specif
b
cell
sort
use
side
doublet
discrimin
follow
gate
b
cell
bound
tetram
tetram
contain
isotyp
control
antibodi
also
sort
control
igmd
b
cell
two
individu
stain
antiidiotyp
singl
cell
sort
individu
well
pcr
plate
eppendorf
contain
icecold
lysi
buffer
contain
u
rnaseout
thermo
fisher
scientif
superscript
iv
first
strand
buffer
thermo
fisher
scientif
dithiothreitol
thermo
fisher
scientif
igep
deterg
sigmaaldrich
diethyl
water
plate
seal
adhes
pcr
plate
seal
thermo
fisher
scientif
centrifug
briefli
immedi
frozen
dri
ice
storag
rt
perform
use
superscript
iv
thermo
fisher
scientif
previous
describ
tiller
et
al
wu
et
al
briefli
rt
reaction
mix
consist
random
hexam
thermo
fisher
scientif
mm
deoxyribonucleotid
triphosph
dntp
thermo
fisher
scientif
u
superscript
iv
rt
water
ad
well
contain
singl
sort
b
cell
lysi
buffer
incub
h
follow
rt
cdna
ad
pcr
reaction
mix
final
reaction
contain
u
hotstartaq
polymeras
qiagen
revers
primer
forward
primer
mm
dntp
buffer
qiagen
water
pcr
program
cycl
min
igmiggkappa
light
chain
cycl
min
lambda
light
chain
first
round
pcr
pcr
product
ad
secondround
pcr
reaction
final
reaction
contain
u
hotstartaq
polymeras
revers
primer
forward
primer
mm
dntp
buffer
water
pcr
program
first
round
pcr
pcr
product
run
agaros
gel
confirm
presenc
heavi
chain
band
light
chain
band
pcr
reaction
show
presenc
heavi
light
chain
amplicon
mix
exosapit
thermo
fisher
scientif
incub
min
follow
min
hydrolyz
excess
primer
nucleotid
hydrolyz
secondround
pcr
product
sequenc
genewiz
respect
revers
primer
sequenc
analyz
use
imgtvquest
identifi
v
j
gene
segment
control
antibodi
previou
describ
hoot
et
al
liao
et
al
mcguir
et
al
b
pair
heavi
chain
vdj
light
chain
vj
sequenc
bcr
sequenc
experi
naiv
b
cell
identifi
previous
dekoski
et
al
codon
optim
clone
express
vector
contain
human
igk
igl
constant
region
use
infus
clone
clontech
bli
assay
perform
octetr
instrument
fortebio
antiidiotyp
bind
screen
antimous
igg
captur
sensor
fortebio
immers
kinet
buffer
pb
bsa
tween
ph
contain
purifi
antiidiotyp
antibodi
load
baselin
signal
record
kinet
buffer
sensor
immers
kinet
buffer
contain
purifi
human
antibodi
associ
step
maximum
respons
determin
averag
nanomet
shift
last
associ
step
subtract
background
signal
analytecontain
well
use
empti
antimous
igg
fc
captur
sensor
time
point
kinet
analys
perform
room
temperatur
shake
rpm
antimous
ig
captur
sensor
immers
kinet
buffer
contain
purifi
antiidiotyp
antibodi
load
baselin
signal
record
kinet
buffer
sensor
next
immers
well
contain
serial
dilut
purifi
fab
kinet
buffer
associ
phase
follow
immers
kinet
buffer
addit
dissoci
phase
background
signal
measur
analytecontain
well
use
sensor
load
neg
control
antibodi
subtract
signal
obtain
correspond
ligandcoupl
sensor
time
point
kinet
analys
perform
least
twice
independ
prepar
analyt
dilut
seri
curv
fit
perform
use
bind
model
fortebio
data
analysi
softwar
mean
rate
rate
valu
determin
averag
bind
curv
dilut
seri
match
theoret
fit
valu
zeu
ifa
ana
test
system
use
recommend
manufactur
zeu
scientif
minor
chang
briefli
slide
incub
antibodi
mgml
min
room
temperatur
slide
wash
three
time
dpb
follow
incub
mgml
goat
antihuman
igg
alexa
fluor
thermo
fisher
scientif
dpb
min
room
temperatur
dark
wash
three
time
dpb
slide
incub
zeu
ifa
ana
test
system
fix
coverslip
appli
imag
acquir
use
evo
cell
imag
system
thermo
fisher
scientif
analyz
use
imagej
determin
averag
alexa
fluor
fluoresc
per
cell
imag
igg
purifi
hybridoma
digest
activ
ficin
agaros
resin
thermo
fisher
scientif
h
obtain
fab
fab
gener
digest
ly
c
roch
mg
igg
overnight
fab
purifi
fc
region
collect
fraction
bind
protein
column
thermo
fisher
scientif
size
exclus
chromatographi
use
superdex
ge
healthcar
life
scienc
mm
hepe
mm
nacl
cscfv
clone
express
use
lentiviralbas
stabl
transduct
human
embryon
kidney
suspens
adapt
freestyl
cell
thermo
fisher
scientif
describ
previous
bandaranayak
et
al
briefli
plasmid
contain
appropri
construct
incorpor
replicationincompet
lentivir
particl
transduc
human
embryon
kidney
suspens
adapt
freestyl
cell
plate
fresh
media
ml
incub
humid
cell
supplement
ml
fresh
freestyl
media
h
transduct
follow
transduct
cell
replat
cell
densiti
cultur
larg
liter
cultur
supernat
harvest
centrifug
rpm
remov
cell
clarifi
pass
filter
thermo
fisher
scientif
clarifi
supernat
supplement
mm
nacl
concentr
use
molecular
weight
cutoff
amicon
stir
cell
concentr
emd
millipor
recombin
protein
purifi
size
exclus
chromatographi
use
superdex
andor
superdex
column
ge
healthcar
run
mm
piperazinen
acid
ph
mm
nacl
mm
edta
elut
fraction
analyz
use
sdspage
assess
puriti
protein
concentr
determin
use
molar
extinct
coeffici
absorb
nm
complex
fab
cscfv
fab
fab
form
mix
compon
molar
ratio
incub
overnight
complex
purifi
size
exclus
chromatographi
use
superdex
mm
hepe
mm
nacl
ph
crystal
fab
cscfv
fab
fab
obtain
use
mosquito
dispens
robot
screen
done
use
commerci
avail
screen
rigaku
wizard
precipit
synergi
block
molecular
dimens
proplex
screen
hampton
research
crystal
screen
ht
mix
proteinreservoir
vapor
diffus
method
crystal
use
diffract
data
grown
follow
condit
fab
fab
crystal
grown
solut
contain
ammonium
phosphat
monobas
tri
ph
fab
cscfv
crystal
grown
solut
contain
polyethylen
glycol
peg
tri
ph
use
vapor
diffus
method
crystal
cryoprotect
solut
contain
molar
excess
origin
reagent
glycerol
fab
fab
butanediol
fab
cscfv
crystal
diffract
fab
fab
fab
cscfv
data
collect
advanc
light
sourc
process
use
otwinowski
minor
structur
solv
molecular
replac
use
phaser
collabor
comput
project
number
pdb
access
number
zhou
et
al
matur
portion
search
model
iter
round
structur
build
refin
perform
coot
emsley
cowtan
phenix
adam
et
al
refin
statist
summar
tabl
structur
figur
made
pymol
delano
atom
coordin
structur
factor
complex
xray
crystal
structur
deposit
protein
data
bank
heavi
light
chain
sequenc
deposit
genbank
tabl
contain
sequenc
inform
control
antibodi
use
fig
c
tabl
contain
sequenc
inform
heavi
light
chain
sequenc
deriv
b
cell
bind
tetram
cocktail
tabl
contain
sequenc
inform
heavi
light
chain
sequenc
deriv
human
b
cell
bind
tetram
tabl
contain
sequenc
inform
heavi
light
chain
sequenc
deriv
human
b
cell
bind
tetram
tabl
contain
data
collect
refin
statist
crystal
structur
shown
fig
